Navigation Links
Uptake of Next-Generation Antifungals Has Intensified Competition in the Severe Fungal Infections Drug Market
Date:11/19/2008

However, Generic Erosion and a Dearth of Promising Emerging Therapies Will Result in Modest Annual Growth, According to a New Report from Decision Resources

WALTHAM, Mass., Nov. 19 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to their improvements in safety and efficacy, physicians are increasingly prescribing next-generation antifungals such as Pfizer's Vfend, Schering-Plough's Noxafil, Merck's Cancidas, Astellas' Mycamine and Pfizer's Eraxis. Following the recent launches of several next-generation azoles (such as Vfend and Noxafil) and echinocandins (such as Cancidas, Mycamine and Eraxis), the severe fungal infections market has become increasingly competitive.

The new Pharmacor report entitled Severe Fungal Infections finds that market competition will continue to intensify and the generic erosion of key agents and a dearth of promising emerging therapies will limit growth to a modest two percent annually from 2007 to 2017 in the severe fungal infections drug market. The report also finds that no new products other than Basilea's isavuconazole are expected to generate significant sales in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan through 2017.

"Interviewed physicians regard isavuconazole as a highly promising new antifungal, and we forecast the agent to be an important driver in the severe fungal infection market through 2017," said Jose Avalos, Ph.D., analyst at Decision Resources. "Isavuconazole provides a favorable spectrum of activity and safety and is likely to be available as both an oral and intravenous therapy. This agent will compete with other marketed drugs in its class and its sales will help offset the declines due to patent expiries of key brands over the next 10 years."

About Severe Fungal Infections'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016
2. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
3. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
4. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
5. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
6. Researchers find roadmap to next-generation cancer therapies
7. Fourth Annual Games for Health Conference Joins Health and Gaming Innovators to Discuss Next-Generation Game Technologies and Health Issues
8. VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System
9. iCAD Introduces Next-Generation TotalLook Film Digitizer
10. Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
11. Boston Scientific Announces CE Mark Approval for Next-Generation Cardiac Resynchronization Therapy Defibrillator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... FL (PRWEB) November 28, 2014 Miami's ... responsive website. Practice founder Dr. Jeffrey Epstein ... Created using a groundbreaking WordPress platform, the site ... , Currently, up to 75% of all ... than ever, these people are logging on with smartphones, ...
(Date:11/28/2014)... Australia (PRWEB) November 28, 2014 ... undergone healthy growth over the past five years. ... increasing acceptance of therapies that are either alternative ... treatments. According to IBISWorld industry analyst David Whytcross, ... ageing population and growing private health insurance membership.” ...
(Date:11/28/2014)... 28, 2014 Written and narrated by award ... Voices releases the “The Happiest Man In the World: ... account of how and why Project C.U.R.E. came to be. ... mother Josie and the Reverend Richard W. Jackson, Dr. Jackson ... of 30, but realized that he wasn’t happy. Prompted by ...
(Date:11/28/2014)... -- Planning on seconds at Thanksgiving Day dinner this year? ... gastroesophageal reflux disease (GERD) -- a few steps may help ... and throat specialist at Lenox Hill Hospital in New York ... Thanksgiving: Pace yourself. Rather than have ... the day. It,s also a good idea to have a ...
(Date:11/28/2014)... only is the Éminence Organic Skin Care team proud ... cancer-causing agents, but they are also proud to support ... help in the fight against breast cancer. This year, ... contribution of $30,000 through participation in the CIBC Run ... Whip Moisturizer and the company’s corporate donation. , On ...
Breaking Medicine News(10 mins):Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3
... PICK: Depleting breast cancerinitiating cells by targeting the protein ... types of cancer, including breast cancer, are initiated and ... tumor known as cancer stem cells. These cells are ... recurrence after treatment, meaning that many researchers are seeking ...
... and genitals respond differently to sexual arousal, whereas in ... more in tune with each other, according to Assistant ... and her international collaborators, Michael Seto, Martin Lalumire, Ellen ... of agreement between subjective ratings and physiological measures of ...
... functions early in myogenesis to help stem cells proliferate in ... Reserve University. The study appears online Jan. 4 in the ... MyoD is a transcription factor that activates muscle-specific genes ... fibers. But MyoD is also expressed at an earlier stage ...
... University of Rochester Medical Center researchers have pinpointed the ... highest risk for developing major depression. The researchers, ... at the Medical Center, reported their findings in an ... Journal of Psychiatry . Preventive treatments for people ...
... at fitness ,boot camps, , THURSDAY, Dec. 31 (HealthDay ... pooch. , Boot camps designed for people and ... looking for a one-stop fitness program. , During the 60-minute ... focusing on strength, balance and cardiovascular challenges, as well as ...
... LOS ANGELES, Dec. 31 Numbers are not just statistics. Sometimes ... the preceding century when lives became daily body counts in televised ... is certainly not the only organization whose staff have worked ... selfless staffs of all humanitarian groups and those individual human beings ...
Cached Medicine News:Health News:JCI online early table of contents: January 4, 2009 2Health News:JCI online early table of contents: January 4, 2009 3Health News:JCI online early table of contents: January 4, 2009 4Health News:Women's bodies and minds agree less than men's on what's sexy 2Health News:Study identifies those elderly most at risk for major depression 2Health News:Add Some Woof! to Your Workout 2Health News:Add Some Woof! to Your Workout 3Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 2Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 3
(Date:11/28/2014)... Nov. 28, 2014  Valeant Pharmaceuticals International, Inc. ... announced that its wholly owned subsidiary, Valeant Pharmaceuticals ... of its outstanding 6.875% Senior Notes due 2018, ... on December 29, 2014 and has mailed an ... the redemption, approximately US$500 million aggregate principal amount ...
(Date:11/28/2014)... 2014 /CNW Telbec/ - Ergoresearch Ltd « Ergoresearch » (TSXV: ... Dominique Boudreau who will hold the position ... Dominique Boudreau was acting as corporate controler of ... for more than seven years for Laboratoire Langelier, a ... Mrs. Boudreau replaces Mr. Greco who was previously appointed ...
(Date:11/28/2014)... Kan. , Nov. 28, 2014 Aratana ... company focused on the licensing or acquisition, development and ... other companion animals, today announced that it will present ... Conference, to be held December 2-3, 2014, at the ... . Steven St. Peter , ...
Breaking Medicine Technology:Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018 2Ergoresearch announces the appointment of its new Vice Président Finance 2Ergoresearch announces the appointment of its new Vice Président Finance 3Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2
The intended use of the percutaneous PREFACE Guiding Sheath is for the introduction of intravascular electrophysiology catheters into any cardiac chamber....
... Fast-Cath, Maximum, Maximum Xtra, and Maximum ... of standard and specialty hemostasis introducers ... as the premier hemostasis introducers for ... procedures including angiography, angioplasty, stenting, atherectomy, ...
Rapid Exchange Stent Delivery System with Hepacoat...
A steerable diagnostic catheter with optimal maneuverability...
Medicine Products: